Patents by Inventor Soeren Brogger Christensen

Soeren Brogger Christensen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8772226
    Abstract: Various embodiments of this invention relate generally to targeted activation and delivery of therapeutic drugs to cells that produce prostate specific antigen (PSA), prostate specific membrane antigen (PSMA) or human glandular kallikrein (hK2). Various further embodiments relate more specifically to PSMA-specific peptide prodrugs that become activated to yield therapeutic drugs. Further aspects of various embodiments of the present invention also relate to methods and compositions for treating or preventing cancers and methods and compositions for detecting and/or imaging cancers.
    Type: Grant
    Filed: March 17, 2010
    Date of Patent: July 8, 2014
    Assignee: The Johns Hopkins University
    Inventors: Samuel Ray Denmeade, John Tod Isaacs, Soeren Brogger Christensen
  • Publication number: 20120093724
    Abstract: Various embodiments of this invention relate generally to targeted activation and delivery of therapeutic drugs to cells that produce prostate specific antigen (PSA), prostate specific membrane antigen (PSMA) or human glandular kallikrein (hK2). Various further embodiments relate more specifically to PSMA-specific peptide prodrugs that become activated to yield therapeutic drugs. Further aspects of various embodiments of the present invention also relate to methods and compositions for treating or preventing cancers and methods and compositions for detecting and/or imaging cancers.
    Type: Application
    Filed: March 17, 2010
    Publication date: April 19, 2012
    Applicant: THE JOHNS HOPKINS UNIVERSITY
    Inventors: Samuel Ray Denmeade, John Thomas Isaacs, Soeren Brogger Christensen
  • Patent number: 7084122
    Abstract: Glycosides of diacylglycerol, e.g. 3-?-D-galactopyranosyloxy-2-(octadeca-9Z,12Z,15Z-trienoyloxy)propanyl octadeca-9Z,12Z,15Z-trienoate (GOPO), which was isolated from extracts of rose-hips by activity guided fractionation, can be used as an oral anti-inflammatory agent for the treatment of inflammatory diseases such as arthritis and osteoarthrosis.
    Type: Grant
    Filed: November 21, 2002
    Date of Patent: August 1, 2006
    Inventors: Erik Larsen, Arsalan Kharazmi, Søren Brøgger Christensen, Lars Porskjær Christensen, Kirsten Brandt
  • Patent number: 6603046
    Abstract: The invention is drawn to novel bis-aromatic a,&bgr;-unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria.
    Type: Grant
    Filed: May 27, 1998
    Date of Patent: August 5, 2003
    Assignee: Lica Pharmaceuticals A/S
    Inventors: Arsalan Kharazmi, Søren Brøgger Christensen, Chen Ming, Thor Grundtvig Theander